Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries

The hexavalent vaccines DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib are routinely used for primary immunization of infants against diphtheria, tetanus, pertussis, hepatitis B virus, poliomyelitis, and Haemophilus influenzae type b. A recent publication showed that after primary immunization with these v...

Full description

Bibliographic Details
Main Authors: Marina George, Jaime Pérez Martin, Mohammad AbdelGhany, Foteini Gkalapi, Nicolas Jamet, Richelle C. Kosse, Yara Ruiz García, Elisa Turriani, Valérie Berlaimont
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
absolute risk reduction
adverse reaction
hexavalent vaccine
infants
reactogenicity
simulation
vaccination
Online Access:http://dx.doi.org/10.1080/21645515.2023.2202124

Internet

http://dx.doi.org/10.1080/21645515.2023.2202124

Similar Items